Skip to main content
Veterinary Medicines

Paramove, 49.5% w/w Hydrogen Peroxide concentrate for solution for fish treatment

Authorised
  • Hydrogen peroxide

Product identification

Medicine name:
Paramove, 49.5% w/w Hydrogen Peroxide concentrate for solution for fish treatment
Paramove, 49,5 % w/w hydrogenperoksid konsentrat til behandlingsoppløsning til fisk.
Active substance:
  • Hydrogen peroxide
Target species:
  • Atlantic salmon
Route of administration:
  • Dipping

Product details

Active substance and strength:
  • Hydrogen peroxide
    49.50
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Concentrate for solution for fish treatment
Withdrawal period by route of administration:
  • Dipping
    • Atlantic salmon
      • Meat
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QD08AX01
Authorisation status:
  • Valid
Authorised in:
  • Norway
Package description:
  • Reusable stainless steel ISO-containers of 22,900 Kg.
  • Reusable stainless steel ISO-containers of 26,000 Kg.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Solvay Chemicals International
Marketing authorisation date:
Manufacturing sites for batch release:
  • Solvay Chimie
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 11-8486
Date of authorisation status change:
Reference member state:
  • Norway
Procedure number:
  • NO/V/0013/001
Concerned member states:
  • Ireland
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 9/08/2024
Download
Norwegian (PDF)
Published on: 20/08/2024

Package Leaflet

English (PDF)
Published on: 9/08/2024
Download
Norwegian (PDF)
Published on: 20/08/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."